Sanofi Genzyme is the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, immunology, and oncology. They help people with debilitating and complex conditions that are often difficult to diagnose and treat. They are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world. Genzyme became part of Sanofi in 2011. While continuing to focus on rare diseases, they also established ourselves as a leader in the field of multiple sclerosis. In 2016, their focus expanded to include Sanofi’s programs in oncology and immunology. Their approach is shaped by a long history of developing highly specialized treatments and forging close relationships with physician and patient communities. Founded as Genzyme in Boston in 1981, they rapidly grew to become one of the world’s leading biotechnology companies, recognized for their pioneering development of treatments for rare genetic disorders and their innovative contributions to medical science and biomanufacturing.

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

DaXingAnLing Lingonberry Boreal Biotech Co., Ltd. specializes in herb and plant extracts and food supplements. The firm’s products include organic products, anthocyanidins series, natural colorant and pigment, natural cosmetics raw materials, plant protein, wild fruit and vegetable powder, wild plant extract, and pesticide free products. The company was founded in 2002 and is headquartered in DaXingAnLing City, China.

Nanjing Zelang Pharmaceutical Technology Co., Ltd., established on 2008-01-08, The business scope includes the development of plant extracts,processing,Sales and related technology transfer and service;medicine,food,Health food research and development;Cosmetic sales,Primary Agricultural Sales;cereals,vegetable,planting of flowers;Promotion of planting technology of Chinese herbal medicines.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Shuangjun Biotechnology Co., Ltd., established on 2004-04-16, Business scope includes general items:Biochemical product technology research and development;Research and development of bio-based materials technology;Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals);Bio-feed R&D;Feed Raw Material Sales;Healthy food(prepackaged)Sales;Food Additive Sales;Chemical product sales(No licensed chemical products);Cosmetics Wholesale;Sales of daily chemical products;internet sales(Except for products that require a license for sale);Manufacturing of daily chemical products;Import and export;Food Internet Sales(Only sell prepackaged food).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:pharmaceutical production;food production;food sales;Health food production;Food additive production;Cosmetic production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Avigen, Inc., a biopharmaceutical company, engages in identifying and developing products to treat patients with neurological and other disorders. The company develops the AV411 portfolio, which includes the phase II-stage lead drug compound and proprietary analogs and represents novel, non-opioid drugs for the treatment of various large pain and drug addiction indications. AV411 is an orally bioavailable small molecule; a glial attenuator that suppresses pro-inflammatory cytokines IL-1 beta, TNF alpha, and IL-6; and a toll-like receptor 4 (TLR4) functional antagonist that may contribute to its attenuation of neuroinflammation. AV411 is being evaluated in Phase Ib/IIa clinical trials. The company was founded in 1992 and is headquartered in Alameda, California. As of December 18, 2009, Avigen, Inc. operates as a subsidiary of MediciNova Inc

Institute for Advanced Engineering is an industrial technology research and development company.

Heilongjiang Dinghengsheng Pharmaceutical Co., Ltd. engages in the manufacture of pharmaceutical products. It offers pharmaceutical products in the form of tablets, capsules, and granules. The company was founded on August 27, 1996 and is headquartered in Qiqihar, China.

Chengdu Hesheng Biotechnology Co., Ltd., established on 2009-07-16, Business scope includes biotechnology promotion;Production,Sales of chemical products(Free of Hazardous Chemicals);Sales instrumentation;Rough processing of agricultural products;Import and export(National law,Except where prohibited by administrative regulations;law,Operations can only be carried out after obtaining a license restricted by administrative regulations). (The above business items do not include laws,Projects that require pre-approval or licensing in accordance with regulations and State Council decisions).

Part of China Biologic Products Holdings, Inc., Shandong Taibang Biological Products Co. Ltd. is a Chinese company located in Tai'an that manufactures and wholesales biological products. It was founded in 2002. Guang Li Pang has been the CEO since the inception date.

Shenyang Tianfeng Bio-Pharmaceutical Co., Ltd., established on 2005-01-27, Business scope includes raw materials(Lecithin,Panax ginseng total saponins)medical supplements[Soy lecithin,Soy lecithin(for injection),egg yolk lecithin,egg yolk lecithin(for injection)],new food ingredients,Production and sales of phospholipid products;anti-(suppress)Bacterial preparation:liquid(purify)manufacture;drinks(protein drinks,other beverages)manufacture.Paclitaxel and its natural product purification;Research on related technologies of natural products,to develop,transfer,Serve;Agricultural and sideline products(marigold)buy,processing;Food additive manufacturing;Feed additive manufacturing;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

NeraPharm spol sro, a subsidiary of Cayman Chemical Co., Inc., is a company headquartered in Neratovice, Czech Republic, focused on pharmaceutical preparations. The firm was acquired by Cayman Chemical Co., Inc. on October 09, 2006 for $6 million.

Yissum is the technology transfer company of The Hebrew University of Jerusalem. Founded in 1964, it is the 3rd company of its kind ever created, and has a rich tradition of innovation and commercialization. Through our efforts to identify and create breakthrough scientific research at Hebrew University, we aspire to advance commercial solutions to the most pressing global challenges facing humanity. (Contact Tamir Huberman) Some of our well-known spin-off companies include Mobileye, Orcam, Collplant, Qlight, and Briefcam. Yissum’s business partners span the globe and include companies such as Novartis, Johnson & Johnson, Merck, Intel, Google, Boston Scientific, ICL and many more. Since its inception, Yissum has registered 10,000+ patents covering 2,800+ inventions; licensed 900 technologies and produced 130+ spin-off companies.

Weihe Pharma engages research and development of biopharmaceutical health products, and is at the leading level in the research, development, and large-scale production of medicinal material Panax notoginseng.

Jiangxi China Tobacco Industry Co., Ltd., established on 2004-10-08, Business scope includes cigarette production and sales;cigarette paper,filter stick,Purchase of tobacco tow;Cigar production and sales;Purchase of Tobacco Special Machinery;tobacco leaf,cut tobacco,Purchase of recured tobacco leaves(Valid until2024year7moon24day).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Wuhan Lvfu Biological Engineering Co., Ltd., established on 2000-10-10, Business scope includes plant extracts,Natural colouring,food additives,biopharmaceuticals,Aquatic products,Fruit and vegetable products,potato products,drinks,Research and development of seaweed extract,Manufacturing and sales;Import and export;Technology Import and Export;Agent import and export;Agricultural and sideline products(Does not contain grain)Acquisition and sale;Realtor.(Projects subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangxi China Tobacco Industry Co., Ltd., established on 1990-07-31, Business scope includes cigarette production,Sales;tobacco leaf,cut tobacco,Purchase of recured tobacco leaves;cigarette paper,filter stick,Purchase of tobacco tow;Purchase of Tobacco Special Machinery;Supply of tobacco monopoly products required for joint processing;Other production and operation related to the production and sales of tobacco products;Asset Management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Hanmi Science Co., Ltd. engages in the management of its subsidiaries. It is mainly engaged in the manufacturing and selling of pharmaceutical ingredients and intermediates. The company was founded on June 15,1973 and is headquartered in Hwaseong-si, South Korea.

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.

China Tobacco Henan Industrial Co. Ltd. is a private company headquartered in China that manufactures and sells tobacco products.